KHAN , R. et al. 2024. DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Biological and Clinical Sciences Research Journal. 2024, 1 (Jan. 2024), 654. DOI:https://doi.org/10.54112/bcsrj.v2024i1.654.